We are live on ! Find out more
QEI

QSV Equity Investors Portfolio holdings

AUM $67.6M
1-Year Est. Return 0.29%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
-0.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96M
AUM Growth
-$645K
Cap. Flow
+$333K
Cap. Flow %
0.35%
Top 10 Hldgs %
22.57%
Holding
95
New
8
Increased
17
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$1.38M
2
CBT icon
Cabot Corp
CBT
+$1.23M
3
GNTX icon
Gentex
GNTX
+$1.19M
4
KWR icon
Quaker Houghton
KWR
+$1.16M
5
TNC icon
Tennant Co
TNC
+$1.01M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$1.72M
2
NSP icon
Insperity
NSP
+$1.6M
3
CLB icon
Core Laboratories
CLB
+$1.33M
4
HWKN icon
Hawkins
HWKN
+$1.32M
5
SLP icon
Simulations Plus
SLP
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 25.66%
2 Technology 17.96%
3 Industrials 13.07%
4 Healthcare 11.68%
5 Real Estate 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXP icon
26
LXP Industrial Trust
LXP
$3.58B
$1.43M 1.49%
34,693
-289
-0.8% -$11.9K
GNTX icon
27
Gentex
GNTX
$5.02B
$1.43M 1.49%
65,095
+54,248
+500% +$1.19M
GMED icon
28
Globus Medical
GMED
$11.7B
$1.43M 1.49%
24,252
+8,551
+54% +$552K
HWC icon
29
Hancock Whitney
HWC
$6.23B
$1.42M 1.48%
24,668
-209
-0.8% -$11.1K
WD icon
30
Walker & Dunlop
WD
$1.49B
$1.41M 1.47%
20,028
-163
-0.8% -$11.8K
AUDC icon
31
AudioCodes
AUDC
$255M
$1.33M 1.38%
135,187
-2,407
-2% -$22K
WHD icon
32
Cactus
WHD
$5.7B
$1.3M 1.35%
29,664
+7,649
+35% +$319K
ADUS icon
33
Addus HomeCare
ADUS
$2.23B
$1.28M 1.33%
11,105
-281
-2% -$30.4K
WDFC icon
34
WD-40
WDFC
$3.15B
$1.27M 1.32%
5,570
+25
+0.5% +$5.88K
POWI icon
35
Power Integrations
POWI
$3.46B
$1.25M 1.31%
22,419
-333
-1% -$17.1K
NXRT
36
NexPoint Residential Trust
NXRT
$641M
$1.25M 1.3%
37,471
-2,227
-6% -$78.8K
UFPI icon
37
UFP Industries
UFPI
$5.01B
$1.23M 1.29%
12,417
-196
-2% -$19.8K
MBUU icon
38
Malibu Boats
MBUU
$568M
$1.23M 1.28%
39,116
-321
-0.8% -$9.66K
HBNC icon
39
Horizon Bancorp
HBNC
$1.03B
$1.21M 1.26%
78,760
-649
-0.8% -$9.53K
CBT icon
40
Cabot Corp
CBT
$4.46B
$1.2M 1.25%
+16,018
New +$1.23M
KWR icon
41
Quaker Houghton
KWR
$2.96B
$1.19M 1.24%
+10,638
New +$1.16M
KLIC icon
42
Kulicke & Soffa
KLIC
$4.53B
$1.19M 1.24%
34,285
-288
-0.8% -$9.37K
FAF icon
43
First American
FAF
$7.37B
$1.17M 1.22%
19,037
-410
-2% -$24.3K
CPRX
44
DELISTED
Catalyst Pharmaceutical
CPRX
$1.16M 1.21%
53,438
-30,426
-36% -$718K
USPH icon
45
US Physical Therapy
USPH
$1.24B
$1.16M 1.2%
14,785
-123
-0.8% -$9.07K
KAI icon
46
Kadant
KAI
$3.94B
$1.16M 1.2%
3,639
-31
-0.8% -$9.7K
AWR icon
47
American States Water
AWR
$3.43B
$1.15M 1.2%
14,971
-130
-0.9% -$10.2K
CGNX icon
48
Cognex
CGNX
$10.8B
$1.14M 1.19%
35,964
-109
-0.3% -$3.12K
VSTS icon
49
Vestis
VSTS
$1.83B
$1.13M 1.18%
197,034
+81,737
+71% +$574K
CNS icon
50
Cohen & Steers
CNS
$4.22B
$1.11M 1.16%
14,743
-266
-2% -$20.4K
1
2
3 4

Similar funds

BBW
Blue Barn Wealth Orem, Utah $68.7M AUM 16.42% 1-Year Est. Return
YCM
Yost Capital Management Houston, Texas $68.9M AUM 18.32% 1-Year Est. Return
RWA
Redmont Wealth Advisors Chicago, Illinois $66M AUM 13.09% 1-Year Est. Return
KWM
KW Wealth Management Sacramento, California $65.9M AUM
IA
Incentive AS Oslo, Norway $71.3M AUM 30.74% 1-Year Est. Return
MCL
MWG Caph Ltd Charlestown $72.4M AUM
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return

QSV Equity Investors's Q2 2025 Portfolio in Review

As of Q2 2025, QSV Equity Investors held 95 positions worth $96M, down 0.67% from $96.6M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

QSV Equity Investors's Q2 2025 filing shows 8 new, 17 increased, 52 reduced and 5 closed positions. Its largest new stake was Haemonetics: 20,790 shares worth $1.55M. The largest sale was Medpace, an estimated $1.72M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • QSV Equity Investors's largest Q2 2025 buy was Haemonetics: 20,790 shares worth $1.55M.
  • QSV Equity Investors added most to Gentex in Q2 2025, an estimated $1.19M increase.
  • QSV Equity Investors's biggest Q2 2025 reduction was Catalyst Pharmaceutical, cutting an estimated $718K.
  • QSV Equity Investors fully exited Medpace in Q2 2025, selling an estimated $1.72M.
  • QSV Equity Investors's ten largest holdings make up 23% of its $96M portfolio in Q2 2025.
  • QSV Equity Investors opened 8 new positions and closed 5 in Q2 2025.
  • QSV Equity Investors's portfolio value fell 0.67% quarter-over-quarter to $96M.

Based on QSV Equity Investors's 13F filing for Q2 2025, filed 13 Aug 2025.